MICHAEL GREICO: Open Payments
NPI 1689102055 · MILLVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$194 in 12 payments from 10 companies in 2025. Trend: 2023 $2,138 · 2024 $1,776 · 2025 $194
Food & beverage: $194
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $37 |
| ABBVIE INC. | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Lundbeck LLC | 1 | $16 |
| Amgen Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: Ozempic, REXULTI, Auvelity, BREZTRI, VRAYLAR, QULIPTA, OTEZLA, VOQUEZNA.
Industry payments across NJ — which companies pay providers there.
